Canagliflozin: a new hope in the antidiabetic armamentarium.
Katsi VK, Michalakeas CA, Grassos CE, Vamvakou GD, Lekakis JP, Tousoulis D, Stefanadis CI, Makris TK, Kallikazaros IE.
Katsi VK, et al.
Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):216-20. doi: 10.2174/1574890108666131213100613.
Recent Pat Cardiovasc Drug Discov. 2013.
PMID: 24359233
Review.